MARLA POOLE: Open Payments
NPI 1952953689 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 38 payments from 18 companies in 2025. Trend: 2023 $1,391 · 2024 $45 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $198 |
| PFIZER INC. | 4 | $81 |
| ABBVIE INC. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| SK Life Science, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| MDD US Operations, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: Zilbrysq, NURTEC ODT, Rystiggo, INGREZZA, REXULTI, AUSTEDO XR, UBRELVY, Nayzilam.
Industry payments across GA — which companies pay providers there.
